Welcome to our dedicated page for SGLB news (Ticker: SGLB), a resource for investors and traders seeking the latest updates and insights on SGLB stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SGLB's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SGLB's position in the market.
Sigma Labs (NASDAQ:SGLB) will hold a conference call on April 22, 2021, at 4:30 p.m. Eastern to discuss its first-quarter results for the period ending March 31, 2021. The call will feature President and CEO Mark Ruport and CFO Frank Orzechowski, followed by a Q&A session. Interested parties can join by calling 1-877-407-9039 (toll-free) or 1-201-689-8470 (international). A replay will be available after 7:30 p.m. Eastern until May 6, 2021. The conference will be accessible live via the company’s website.
Sigma Labs, Inc. (NASDAQ:SGLB) has partnered with Ermaksan Innovative Technologies to offer its PrintRite3D In-Process Quality Assurance technology as a factory option on the ENAVISION 3D metal additive machines. The collaboration starts with a contract for an initial system installation in Turkey, aiming for certification before deployment. This partnership focuses on enhancing quality standards and innovation in 3D metal printing manufacturing, aligning with Ermaksan’s commitment to R&D. Sigma Labs predicts the PrintRite3D Ready certification will boost production efficiency and quality assurance in the industry.
Sigma Labs (NASDAQ:SGLB) has successfully completed a $9.7 million registered direct offering, selling 2,190,000 shares of common stock at a price of $4.445 each, alongside short-term warrants. The warrants, priced at $4.32, become exercisable upon shareholder approval to increase authorized shares from 12 million to 24 million. The proceeds will be used for operations, product development, and working capital. The offering was managed by H.C. Wainwright & Co.
Sigma Labs (NASDAQ:SGLB) has entered into securities purchase agreements for a registered direct offering of 2,190,000 shares of common stock at a price of $4.445 each, aiming to raise approximately $9.7 million before expenses. This offering includes short-term warrants exercisable at $4.32 per share. The funds will be used for operations, product development, and working capital. The closing is anticipated on or about March 26, 2021, subject to standard conditions. The offering adheres to Nasdaq regulations and a prior SEC registration.
Sigma Labs, a developer of quality assurance software for the 3D metal printing industry, reported Q4 and full-year 2020 results. Revenue for 2020 was $807,500, a 100% increase from 2019, with Q4 contributing $169,500. The company achieved a net loss of $7.0 million, or $(1.83) per share. Key highlights include a $5.1 million public offering, contracts with Lockheed Martin and Coherent, and partnerships with DMG MORI and Northwestern University. Looking ahead, Sigma aims to expand in aerospace, defense, and other sectors, supported by a robust sales team and strategic alliances.
Sigma Labs (NASDAQ:SGLB) has secured a contract with Lockheed Martin to provide its PrintRite3D in-process quality assurance solution at the Space Additive Design & Manufacturing Center in California. This collaboration aims to enhance the quality and reliability of 3D-printed satellite components for defense and civil space projects. Lockheed Martin's team will evaluate the performance of PrintRite3D, which features machine learning and real-time anomaly detection. Sigma Labs' technology is expected to drive cost savings and production efficiencies in the additive manufacturing sector.
Sigma Labs (NASDAQ:SGLB) will present at the Investor Summit Q1 Virtual Summit from March 23-25, 2021. CEO Mark Ruport will discuss the company's 2020 achievements, 2021 industry outlook, and updates on agreements with DMG MORI, Additive Industries, and Materialise. The presentation is scheduled for March 25, 2021, at 3:30 pm ET. Sigma Labs develops quality assurance software for 3D metal printing, focusing on real-time monitoring with its PrintRite3D technology. For more details, visit sigmalabsinc.com.
Sigma Labs (NASDAQ:SGLB) will conduct a conference call on March 24, 2021, at 4:30 PM ET to discuss its fourth-quarter and full-year 2020 results. The call will feature President and CEO Mark Ruport and CFO Frank Orzechowski, followed by a Q&A session. Interested parties can join by dialing 1-877-407-9039 (toll-free) or 1-201-689-8470 (international). A press release detailing the results will precede the call, and a replay will be available until April 7, 2021.
Sigma Labs (NASDAQ:SGLB) announced its sponsorship of the AM Industry Summit, taking place virtually on March 3-4, 2021. This event, organized by ASME, focuses on enhancing additive manufacturing in the aerospace and energy sectors. Over 60 industry experts will present, aiming to connect professionals and share advancements. Darren Beckett, CTO of Sigma Labs, will discuss the benefits of melt pool monitoring technology during his session. CEO Mark Ruport emphasized the company's commitment to collaboration within the AM industry.
Sigma Labs (NASDAQ:SGLB) has shared a shareholder letter highlighting its 2020 achievements and plans for 2021 amid the challenges posed by COVID-19. The company emphasizes that the global 3D printing market is anticipated to grow significantly, with a CAGR of 26.4% expected to exceed $40 billion by 2024. Key milestones include global partnerships, an expanded product line, and additional patents. The company has also strengthened its management team, adding experienced sales directors. Looking ahead, Sigma Labs aims to innovate and expand its market presence.
FAQ